IMDX
Insight Molecular Diagnostics
IMDX
IMDX
41 hedge funds and large institutions have $62.1M invested in Insight Molecular Diagnostics in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
50% less capital invested
Capital invested by funds: $125M → $62.1M (-$62.8M)
Holders
41
Holding in Top 10
2
Calls
$4K
Puts
–
Top Buyers
| 1 | +$4.88M | |
| 2 | +$3.03M | |
| 3 | +$2.28M | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$1.2M |
| 5 |
FOR
Family Office Research
Bethesda,
Maryland
|
+$739K |
Top Sellers
| 1 | -$319K | |
| 2 | -$280K | |
| 3 | -$180K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$117K |
| 5 |
Renaissance Technologies
New York
|
-$101K |
